VERA
Vera Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
VERA Profile
Vera Therapeutics, Inc.
A biotech company developing novel immunomodulatory therapies for autoimmune diseases and cancer
Biological Technology
Invalid Date
05/14/2021
NASDAQ Stock Exchange
112
12-31
Common stock
8000 Marina Boulevard, Suite 120, Brisbane, California 94005
--
Vera Therapeutics, Inc., originally incorporated in Delaware in May 2016 under the name CDF Therapeutics, Inc., was renamed Vera Therapeutics, Inc., in April 2020. The company is an late-stage clinical biotechnology company focused on developing and commercializing translational therapies for patients with severe immune diseases. The company's lead product candidate, atacicept, is a self-administered fusion protein that blocks B lymphocyte stimulators and proliferation-inducing ligands with best-in-class potential for the treatment of IgA nephropathy.